Scinovex
articleTop 1% cited

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31

International Journal of Radiation Oncology*Biology*Physics · 2005 · Vol. 61(5) · pp. 1285–1290
Miljenko V. PilepichKathryn WinterC.A. LawtonRobert E. KrischHarvey B. WolkovBenjamin MovsasEugen B. HugSucha O. AsbellDavid J. Grignon
Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchUrologic and reproductive health conditionsMedicineGoserelinProstatectomyUrologyRadiation therapyAndrogen suppressionProstateInternal medicineAdjuvantCarcinoma

MeSH terms

AgedAndrogen AntagonistsCombined Modality TherapyHumansMaleProstatectomyProstatic NeoplasmsSurvival RateMultivariate AnalysisChemotherapy, AdjuvantGoserelinAntineoplastic Agents, Hormonal
Citations
918
FWCI
48.84
field-weighted impact
References
20
Percentile
100%
vs. same field & year
Citations per year
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.